Stribild Articles

EU approval for Gilead's Stribild for HIV-1 infection

29 May 2013

EMA advisory backing for Biogen's Tecfidera, Sanofi's Aubagio and Gilead's Stribild; extends use of Bayer's Xarelto; negative for Kynamro

25 March 2013

Study on generic HIV drugs prompts AHF to demand Gilead cuts ARV prices

16 January 2013

Merck & Co and Gilead highlight new data at international HIV meeting

16 November 2012

Gilead's Stribild to reinforce HIV/AIDS revenues as key patents expire

6 November 2012

Gilead's Stribild, formerly "Quad," gets FDA nod

29 August 2012

Showing 1-6 of 6 articles

Go to beginningPrevious
  • 1
NextGo to end